Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline for Complicated Intra-Abdominal Infections
NCT00488306Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tigecycline in Intra-abdominal infection (IAI), sponsored by Pfizer. Primary endpoint: Clinical Response at Test-of-Cure. Started Aug 2006; status: completed.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00488306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488306.